Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis.

International journal of rheumatic diseases - 1 Sept 2017

Lomax Anna J, McGuire Helen M, McNeil Catriona, Choi Clara J, Hersey Peter, Karikios Deme, Shannon Kerwin, van Hal Sebastian, Carr Urszula, Crotty Anne, Gupta Sandeep K, Hollingsworth Jane, Kim Haewon, Fazekas de St Groth Barbara, McGill Neil

Abstract excerpt

AIM: Sarcoidosis is a multisystem granulomatous disease. This condition has a documented association with the diagnosis of melanoma and can be induced in melanoma patients receiving anti-neoplastic therapy. We evaluated a case series of melanoma patients who developed immunotherapy-induced sarcoidosis. METHODS: Three patients with melanoma (n = 1 resected Stage III, n = 2 metastatic) treated with anti-programmed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Hormones
Share to Antineoplastic Agents, Immunological

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Positron-Emission Tomography

Share to Programmed Cell Death 1 Receptor

Share to Sarcoidosis, Pulmonary

Share to Th17 Cells

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 28480561
DOI: 10.1111/1756-185X.13076

Genes

CCR10
CCR4
CCR6
CXCR3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis.PMID 28480561Read ↗

Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient.Semantic proximity Read ↗

BRAF inhibition and the spectrum of granulomatous reactions.Semantic proximity Read ↗

The Role of Diverse Immune Cells in Sarcoidosis.Semantic proximity Read ↗

Immunologic response of sarcoidosis.Semantic proximity Read ↗

Circulating T cells in sarcoidosis have an aberrantly activated phenotype that correlates with disease outcome.Semantic proximity Read ↗

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs.Semantic proximity Read ↗

A sarcoidosis clinician's perspective of MHC functional elements outside the antigen binding site.Semantic proximity Read ↗

PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation.Semantic proximity Read ↗

Comparative Immunohistochemical Analysis of Macrophage Phenotypes in Cutaneous Sarcoid Granuloma, Suture Granuloma, and Lipogranuloma.Semantic proximity Read ↗

Novel cutaneous effects of combination chemotherapy with BRAF and MEK inhibitors: a report of two cases.Semantic proximity Read ↗

Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.Semantic proximity Read ↗

T-Cell Recognition and Cytokine Profile Induced by Melanocyte Epitopes in Patients with HLA-DRB1*0405-Positive and -Negative Vogt-Koyanagi-Harada UveitisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.